QQ客服 官方微博 反馈留言

	Revaluation of Clopidogrel: Let the Data Speak for Themselves
	Liu, Li; Zeng, Fandian; Zeng, Xiaohua; Xue, Qingmei; Nie, Shaoping; Kang, Cailian; Wu, Jianhong; Kang, Qingyun; Wang, Xingao; Liu, Xiaoqing
刊名	JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES
	2010
卷号	30期号:3
关键词	clopidogrel aspirin antiplatelet therapy randomized blinded trial sample size power confidence interval
ISSN号	1672-0733
DOI	10.1007/s11596-010-0346-3
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4095477
专题	武汉大学
推荐引用方式 GB/T 7714	Liu, Li,Zeng, Fandian,Zeng, Xiaohua,et al. Revaluation of Clopidogrel: Let the Data Speak for Themselves[J]. JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES,2010,30(3).
APA	Liu, Li.,Zeng, Fandian.,Zeng, Xiaohua.,Xue, Qingmei.,Nie, Shaoping.,...&Long, Yu.(2010).Revaluation of Clopidogrel: Let the Data Speak for Themselves.JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES,30(3).
MLA	Liu, Li,et al."Revaluation of Clopidogrel: Let the Data Speak for Themselves".JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES 30.3(2010).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。